Quantitatively, CYP2D6 represents approximatively 1% to 4% of all hepatic CYP450 enzymes and metabolizes approximately 25% of medicines authorized for prescription by international agencies (e.g., anti-cancer agents, anti-depressants, anti-psychotics, and opioids) [27]. This evidence concerns the gene CYP2D6 and cancer.